<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36070309</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>After the virus has cleared-Can preclinical models be employed for Long COVID research?</ArticleTitle><Pagination><StartPage>e1010741</StartPage><MedlinePgn>e1010741</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1010741</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1010741</ELocationID><Abstract><AbstractText>Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) can cause the life-threatening acute respiratory disease called COVID-19 (Coronavirus Disease 2019) as well as debilitating multiorgan dysfunction that persists after the initial viral phase has resolved. Long COVID or Post-Acute Sequelae of COVID-19 (PASC) is manifested by a variety of symptoms, including fatigue, dyspnea, arthralgia, myalgia, heart palpitations, and memory issues sometimes affecting between 30% and 75% of recovering COVID-19 patients. However, little is known about the mechanisms causing Long COVID and there are no widely accepted treatments or therapeutics. After introducing the clinical aspects of acute COVID-19 and Long COVID in humans, we summarize the work in animals (mice, Syrian hamsters, ferrets, and nonhuman primates (NHPs)) to model human COVID-19. The virology, pathology, immune responses, and multiorgan involvement are explored. Additionally, any studies investigating time points longer than 14 days post infection (pi) are highlighted for insight into possible long-term disease characteristics. Finally, we discuss how the models can be leveraged for treatment evaluation, including pharmacological agents that are currently in human clinical trials for treating Long COVID. The establishment of a recognized Long COVID preclinical model representing the human condition would allow the identification of mechanisms causing disease as well as serve as a vehicle for evaluating potential therapeutics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jansen</LastName><ForeName>Ethan B</ForeName><Initials>EB</Initials><Identifier Source="ORCID">0000-0002-7212-7487</Identifier><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orvold</LastName><ForeName>Spencer N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Physiology, and Pharmacology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swan</LastName><ForeName>Cynthia L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yourkowski</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thivierge</LastName><ForeName>Brittany M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francis</LastName><ForeName>Magen E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Anni</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rioux</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darbellay</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howland</LastName><ForeName>John G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Physiology, and Pharmacology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelvin</LastName><ForeName>Alyson A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0003-0940-0847</Identifier><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OV5-170349</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>VRI-172779</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>OV2- 170357</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005289" MajorTopicYN="N">Ferrets</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008647" MajorTopicYN="N">Mesocricetus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>7</Day><Hour>13</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36070309</ArticleId><ArticleId IdType="pmc">PMC9451097</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1010741</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-22-00625</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, et al.. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan. China J Clin Virol. 2020;127:104364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194884</ArticleId><ArticleId IdType="pubmed">32311650</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay MZ, Poh CM, Renia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363&#x2013;374. doi: 10.1038/s41577-020-0311-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0311-8</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis. Trends Immunol. 2020;41(12):1100&#x2013;15. doi: 10.1016/j.it.2020.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7556779</ArticleId><ArticleId IdType="pubmed">33132005</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194&#x2013;202. doi: 10.1038/s41590-021-01104-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al.. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;15. doi: 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al.. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;32. doi: 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, Tleyjeh IM. Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19. Front Immunol. 2021;12:686029. doi: 10.3389/fimmu.2021.686029</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686029</ArticleId><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;64. doi: 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Perez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jimenez J, et al.. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021;82(3):378&#x2013;83. doi: 10.1016/j.jinf.2021.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma J, Subbarao N. A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics. Arch Virol. 2021;166(3):697&#x2013;714. doi: 10.1007/s00705-021-04961-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-021-04961-y</ArticleId><ArticleId IdType="pmc">PMC7821988</ArticleId><ArticleId IdType="pubmed">33483791</ArticleId></ArticleIdList></Reference><Reference><Citation>Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, et al.. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Db Syst Rev. 2021;2. doi: 10.1002/14651858.CD013665.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013665.pub2</ArticleId><ArticleId IdType="pmc">PMC8407425</ArticleId><ArticleId IdType="pubmed">33620086</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamil S, Mark N, Carlos G, Cruz CSD, Gross JE, Pasnick S. Diagnosis and Management of COVID-19 Disease. Am J Respir Crit Care Med. 2020;201(10):P19&#x2013;P20. doi: 10.1164/rccm.2020C1</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.2020C1</ArticleId><ArticleId IdType="pubmed">32223716</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinato G, Fabbris C, Polesel J, Cazzador D, Borsetto D, Hopkins C, et al.. Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection. JAMA. 2020;323(20):2089&#x2013;90. doi: 10.1001/jama.2020.6771</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6771</ArticleId><ArticleId IdType="pmc">PMC7177631</ArticleId><ArticleId IdType="pubmed">32320008</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose-Sauld S, Dua A. COVID toes and other cutaneous manifestations of COVID-19. J Wound Care. 2020;29(9):486&#x2013;7. doi: 10.12968/jowc.2020.29.9.486</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/jowc.2020.29.9.486</ArticleId><ArticleId IdType="pubmed">32924822</ArticleId></ArticleIdList></Reference><Reference><Citation>Almqvist J, Granberg T, Tzortzakakis A, Klironomos S, Kollia E, Ohberg C, et al.. Neurological manifestations of coronavirus infections&#x2014;a systematic review. Ann Clin Transl Neurol. 2020;7(10):2057&#x2013;71. doi: 10.1002/acn3.51166</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51166</ArticleId><ArticleId IdType="pmc">PMC7461163</ArticleId><ArticleId IdType="pubmed">32853453</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al.. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017&#x2013;32. doi: 10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. The lasting misery of coronavirus long-haulers. Nature. 2020;585(7825):339&#x2013;41. doi: 10.1038/d41586-020-02598-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02598-6</ArticleId><ArticleId IdType="pubmed">32929257</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes (vol 42, pg 505, 2020). Geroscience. 2020;42(3):1013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7145538</ArticleId><ArticleId IdType="pubmed">32274617</ArticleId></ArticleIdList></Reference><Reference><Citation>Meintrup D, Borgmann S, Seidl K, Stecher M, Jakob CEM, Pilgram L, et al.. Specific Risk Factors for Fatal Outcome in Critically Ill COVID-19 Patients: Results from a European Multicenter Study. J Clin Med. 2021;10(17). doi: 10.3390/jcm10173855</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10173855</ArticleId><ArticleId IdType="pmc">PMC8432209</ArticleId><ArticleId IdType="pubmed">34501301</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YM, Shin EC. Type I and III interferon responses in SARS-CoV-2 infection. Exp Mol Med. 2021;53(5):750&#x2013;60. doi: 10.1038/s12276-021-00592-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00592-0</ArticleId><ArticleId IdType="pmc">PMC8099704</ArticleId><ArticleId IdType="pubmed">33953323</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, Moller R, et al.. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020;181(5):1036&#x2013;45 e9. doi: 10.1016/j.cell.2020.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al.. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369(6504):718&#x2013;24. doi: 10.1126/science.abc6027</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021;27(1):28&#x2013;33. doi: 10.1038/s41591-020-01202-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Roltgen K, Boyd SD. Antibody and B cell responses to SARS-CoV-2 infection and vaccination. Cell Host Microbe. 2021;29(7):1063&#x2013;75. doi: 10.1016/j.chom.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8233571</ArticleId><ArticleId IdType="pubmed">34174992</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudbjartsson DF, Norddahl GL, Melsted P, Gunnarsdottir K, Holm H, Eythorsson E, et al.. Humoral Immune Response to SARS-CoV-2 in Iceland. N Engl J Med. 2020;383(18):1724&#x2013;34. doi: 10.1056/NEJMoa2026116</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2026116</ArticleId><ArticleId IdType="pmc">PMC7494247</ArticleId><ArticleId IdType="pubmed">32871063</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Moderbacher CR, et al.. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181(7):1489&#x2013;501 e15. doi: 10.1016/j.cell.2020.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.015</ArticleId><ArticleId IdType="pmc">PMC7237901</ArticleId><ArticleId IdType="pubmed">32473127</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, Faliti CE, et al.. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371(6529). doi: 10.1126/science.abf4063</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf4063</ArticleId><ArticleId IdType="pmc">PMC7919858</ArticleId><ArticleId IdType="pubmed">33408181</ArticleId></ArticleIdList></Reference><Reference><Citation>Wajnberg A, Amanat F, Firpo A, Altman DR, Bailey MJ, Mansour M, et al.. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020;370(6521):1227&#x2013;30. doi: 10.1126/science.abd7728</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd7728</ArticleId><ArticleId IdType="pmc">PMC7810037</ArticleId><ArticleId IdType="pubmed">33115920</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol. 2021;12. doi: 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Margalit I, Yahav D, Runold M, Bruchfeld J. Long COVID-19-it&#x2019;s not over until? Clin Microbiol Infect. 2021;27(4):506&#x2013;8. doi: 10.1016/j.cmi.2020.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.12.001</ArticleId><ArticleId IdType="pmc">PMC7832095</ArticleId><ArticleId IdType="pubmed">33316400</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus
2021. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers. J Med Virol. 2021;93(5):2555&#x2013;6. doi: 10.1002/jmv.26624</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon-Ceron D, Slama D, De Broucker T, Karmochkine M, Pavie J, Sorbets E, et al.. Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study. J Infect. 2021;82(2):e1&#x2013;e4. doi: 10.1016/j.jinf.2020.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.12.002</ArticleId><ArticleId IdType="pmc">PMC7833274</ArticleId><ArticleId IdType="pubmed">33285216</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebina-Shibuya R, Namkoong H, Shibuya Y, Horita N. Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases. Int J Infect Dis. 2020;97:371&#x2013;3. doi: 10.1016/j.ijid.2020.06.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.06.014</ArticleId><ArticleId IdType="pmc">PMC7293840</ArticleId><ArticleId IdType="pubmed">32553716</ArticleId></ArticleIdList></Reference><Reference><Citation>Radia T, Williams N, Agrawal P, Harman K, Weale J, Cook J, et al.. Multi-system inflammatory syndrome in children &amp; adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatr Respir Rev. 2021;38:51&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417920</ArticleId><ArticleId IdType="pubmed">32891582</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowley AH. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children. Nat Rev Immunol. 2020;20(8):453&#x2013;4. doi: 10.1038/s41577-020-0367-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0367-5</ArticleId><ArticleId IdType="pmc">PMC7296515</ArticleId><ArticleId IdType="pubmed">32546853</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al.. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022. doi: 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Francisco EB, Yogendra R, Long E, Pise A, Rodrigues H, et al.. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection. Front Immunol. 2021;12:746021. doi: 10.3389/fimmu.2021.746021</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AW, Shah AS, Johnston JC, Carlsten C, Ryerson CJ. Patient-reported outcome measures after COVID-19: a prospective cohort study. Eur Respir J. 2020;56(5). doi: 10.1183/13993003.03276-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03276-2020</ArticleId><ArticleId IdType="pmc">PMC7530908</ArticleId><ArticleId IdType="pubmed">33008936</ArticleId></ArticleIdList></Reference><Reference><Citation>ONS. Prevalence of long COVID symptoms and COVID-19 complications. UK Office for National Statistics. 2020. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/datasets/prevalenceoflongcovidsymptomsandcovid19complications.</Citation></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al.. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737&#x2013;54. doi: 10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones R, Davis A, Stanley B, Julious S, Ryan D, Jackson DJ, et al.. Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients. Pragmat Obs Res. 2021;12:93&#x2013;104. doi: 10.2147/POR.S316186</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/POR.S316186</ArticleId><ArticleId IdType="pmc">PMC8366779</ArticleId><ArticleId IdType="pubmed">34408531</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files DC, et al.. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network&#x2014;United States, March-June 2020. Mmwr-Morbid Mortal W. 2020;69(30):993&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al.. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;31. doi: 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunti K, Davies MJ, Kosiborod MN, Nauck MA. Long COVID&#x2014;metabolic risk factors and novel therapeutic management. Nat Rev Endocrinol. 2021;17(7):379&#x2013;80. doi: 10.1038/s41574-021-00495-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-021-00495-0</ArticleId><ArticleId IdType="pmc">PMC8054121</ArticleId><ArticleId IdType="pubmed">33875855</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschenberger M, Hunszinger V, Sparrer KMJ. Implications of Innate Immunity in Post-Acute Sequelae of Non-Persistent Viral Infections. Cell. 2021;10(8). doi: 10.3390/cells10082134</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10082134</ArticleId><ArticleId IdType="pmc">PMC8391718</ArticleId><ArticleId IdType="pubmed">34440903</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrakis D, Margina D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, et al.. Obesity-a risk factor for increased COVID-19 prevalence, severity and lethality. Mol Med Rep. 2020;22(1):9&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7248467</ArticleId><ArticleId IdType="pubmed">32377709</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho HE, Goldberg SA, et al.. Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis. 2021;224(11):1839&#x2013;48. doi: 10.1093/infdis/jiab490</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Maecker HT. Immune profiling of COVID-19: preliminary findings and implications for the pandemic. J Immunother Cancer. 2021;9(5). doi: 10.1136/jitc-2021-002550</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2021-002550</ArticleId><ArticleId IdType="pmc">PMC8108128</ArticleId><ArticleId IdType="pubmed">33963016</ArticleId></ArticleIdList></Reference><Reference><Citation>Brocato RL, Kwilas SA, Kim RK, Zeng X, Principe LM, Smith JM, et al.. Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters. NPJ Vaccines. 2021;6(1):16. doi: 10.1038/s41541-020-00279-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-020-00279-z</ArticleId><ArticleId IdType="pmc">PMC7835356</ArticleId><ArticleId IdType="pubmed">33495468</ArticleId></ArticleIdList></Reference><Reference><Citation>Tostanoski LH, Wegmann F, Martinot AJ, Loos C, McMahan K, Mercado NB, et al.. Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters. Nat Med. 2020;26(11):1694&#x2013;1700. doi: 10.1038/s41591-020-1070-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1070-6</ArticleId><ArticleId IdType="pmc">PMC7671939</ArticleId><ArticleId IdType="pubmed">32884153</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni R, Chen WC, Lee Y, Kao CF, Hu SL, Ma HH, et al.. Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters. PLoS ONE. 2021;16(9):e0257191. doi: 10.1371/journal.pone.0257191</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257191</ArticleId><ArticleId IdType="pmc">PMC8428573</ArticleId><ArticleId IdType="pubmed">34499677</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer RJ, van Doremalen N, Adney DR, Yinda CK, Port JR, Holbrook MG, et al.. ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7. Nat Commun. 2021;12(1):5868. doi: 10.1038/s41467-021-26178-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26178-y</ArticleId><ArticleId IdType="pmc">PMC8497486</ArticleId><ArticleId IdType="pubmed">34620866</ArticleId></ArticleIdList></Reference><Reference><Citation>Driouich JS, Cochin M, Lingas G, Moureau G, Touret F, Petit PR, et al.. Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model. Nat Commun. 2021;12(1):1735. doi: 10.1038/s41467-021-21992-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21992-w</ArticleId><ArticleId IdType="pmc">PMC7979801</ArticleId><ArticleId IdType="pubmed">33741945</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenke K, Hansen F, Schwarz B, Feldmann F, Haddock E, Rosenke R, et al.. Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model. Nat Commun. 2021;12(1):2295. doi: 10.1038/s41467-021-22580-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22580-8</ArticleId><ArticleId IdType="pmc">PMC8052374</ArticleId><ArticleId IdType="pubmed">33863887</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaptein SJF, Jacobs S, Langendries L, Seldeslachts L, Ter Horst S, Liesenborghs L, et al.. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity. Proc Natl Acad Sci U S A. 2020;117(43):26955&#x2013;65. doi: 10.1073/pnas.2014441117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2014441117</ArticleId><ArticleId IdType="pmc">PMC7604414</ArticleId><ArticleId IdType="pubmed">33037151</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo GD, Lazarini F, Larrous F, Feige L, Kornobis E, Levallois S, et al.. Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin. EMBO Mol Med. 2021;13(8):e14122. doi: 10.15252/emmm.202114122</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202114122</ArticleId><ArticleId IdType="pmc">PMC8350903</ArticleId><ArticleId IdType="pubmed">34170074</ArticleId></ArticleIdList></Reference><Reference><Citation>Boudewijns R, Thibaut HJ, Kaptein SJF, Li R, Vergote V, Seldeslachts L, et al.. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters. Nat Commun. 2020;11(1):5838. doi: 10.1038/s41467-020-19684-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19684-y</ArticleId><ArticleId IdType="pmc">PMC7672082</ArticleId><ArticleId IdType="pubmed">33203860</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan JF, Zhang AJ, Yuan S, Poon VK, Chan CC, Lee AC, et al.. Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility. Clin Infect Dis. 2020;71(9):2428&#x2013;46. doi: 10.1093/cid/ciaa325</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa325</ArticleId><ArticleId IdType="pmc">PMC7184405</ArticleId><ArticleId IdType="pubmed">32215622</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai M, Iwatsuki-Horimoto K, Hatta M, Loeber S, Halfmann PJ, Nakajima N, et al.. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci U S A. 2020;117(28):16587&#x2013;95. doi: 10.1073/pnas.2009799117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2009799117</ArticleId><ArticleId IdType="pmc">PMC7368255</ArticleId><ArticleId IdType="pubmed">32571934</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts A, Vogel L, Guarner J, Hayes N, Murphy B, Zaki S, et al.. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J Virol. 2005;79(1):503&#x2013;11. doi: 10.1128/JVI.79.1.503-511.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.1.503-511.2005</ArticleId><ArticleId IdType="pmc">PMC538722</ArticleId><ArticleId IdType="pubmed">15596843</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenke K, Meade-White K, Letko M, Clancy C, Hansen F, Liu Y, et al.. Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection. Emerg Microbes Infect. 2020;9(1):2673&#x2013;84. doi: 10.1080/22221751.2020.1858177</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1858177</ArticleId><ArticleId IdType="pmc">PMC7782266</ArticleId><ArticleId IdType="pubmed">33251966</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraj P, Lien CZ, Liu S, Stauft CB, Nunez IA, Hernandez M, et al.. SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters. Life Sci Alliance. 2021;4(4). doi: 10.26508/lsa.202000886</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202000886</ArticleId><ArticleId IdType="pmc">PMC7893819</ArticleId><ArticleId IdType="pubmed">33574037</ArticleId></ArticleIdList></Reference><Reference><Citation>Sia SF, Yan LM, Chin AWH, Fung K, Choy KT, Wong AYL, et al.. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583(7818):834&#x2013;8. doi: 10.1038/s41586-020-2342-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2342-5</ArticleId><ArticleId IdType="pmc">PMC7394720</ArticleId><ArticleId IdType="pubmed">32408338</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Z, Bao L, Yu P, Qi F, Gong S, Wang J, et al.. SARS-CoV-2 Causes a Systemically Multiple Organs Damages and Dissemination in Hamsters. Front Microbiol. 2020;11:618891. doi: 10.3389/fmicb.2020.618891</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.618891</ArticleId><ArticleId IdType="pmc">PMC7835519</ArticleId><ArticleId IdType="pubmed">33510731</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SJ, Wei TC, Hsu CH, Ho SN, Lai CY, Huang SF, et al.. Characterization of Virus Replication, Pathogenesis, and Cytokine Responses in Syrian Hamsters Inoculated with SARS-CoV-2. J Inflamm Res. 2021;14:3781&#x2013;95. doi: 10.2147/JIR.S323026</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S323026</ArticleId><ArticleId IdType="pmc">PMC8366787</ArticleId><ArticleId IdType="pubmed">34408462</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis ME, Goncin U, Kroeker A, Swan C, Ralph R, Lu Y, et al.. SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney. PLoS Pathog. 2021;17(7):e1009705. doi: 10.1371/journal.ppat.1009705</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009705</ArticleId><ArticleId IdType="pmc">PMC8282065</ArticleId><ArticleId IdType="pubmed">34265022</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaecher SR, Stabenow J, Oberle C, Schriewer J, Buller RM, Sagartz JE, et al.. An immunosuppressed Syrian golden hamster model for SARS-CoV infection. Virology. 2008;380(2):312&#x2013;21. doi: 10.1016/j.virol.2008.07.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.07.026</ArticleId><ArticleId IdType="pmc">PMC3722600</ArticleId><ArticleId IdType="pubmed">18760437</ArticleId></ArticleIdList></Reference><Reference><Citation>Luan J, Lu Y, Jin X, Zhang L. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection. Biochem Biophys Res Commun. 2020;526(1):165&#x2013;9. doi: 10.1016/j.bbrc.2020.03.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.03.047</ArticleId><ArticleId IdType="pmc">PMC7102515</ArticleId><ArticleId IdType="pubmed">32201080</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreye J, Reincke SM, Kornau HC, Sanchez-Sendin E, Corman VM, Liu H, et al.. A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model. Cell. 2020;183(4):1058&#x2013;69 e19. doi: 10.1016/j.cell.2020.09.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.049</ArticleId><ArticleId IdType="pmc">PMC7510528</ArticleId><ArticleId IdType="pubmed">33058755</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Che Q, Ji X, Meng X, Zhang L, Jia R, et al.. Correlation between lung infection severity and clinical laboratory indicators in patients with COVID-19: a cross-sectional study based on machine learning. BMC Infect Dis. 2021;21(1):192. doi: 10.1186/s12879-021-05839-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-05839-9</ArticleId><ArticleId IdType="pmc">PMC7891484</ArticleId><ArticleId IdType="pubmed">33602128</ArticleId></ArticleIdList></Reference><Reference><Citation>George PM, Barratt SL, Condliffe R, Desai SR, Devaraj A, Forrest I, et al.. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020;75(11):1009&#x2013;16. doi: 10.1136/thoraxjnl-2020-215314</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215314</ArticleId><ArticleId IdType="pubmed">32839287</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al.. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 2020;295(3):715&#x2013;21. doi: 10.1148/radiol.2020200370</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200370</ArticleId><ArticleId IdType="pmc">PMC7233367</ArticleId><ArticleId IdType="pubmed">32053470</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere JJ, Serafini RA, Pryce KD, Zazhytska M, Oishi K, Golynker I, et al.. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery. Sci Transl Med. 2022. doi: 10.1126/scitranslmed.abq3059</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Oladunni FS, Park JG, Pino PA, Gonzalez O, Akhter A, Allue-Guardia A, et al.. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice. Nat Commun. 2020;11(1):6122. doi: 10.1038/s41467-020-19891-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19891-7</ArticleId><ArticleId IdType="pmc">PMC7705712</ArticleId><ArticleId IdType="pubmed">33257679</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari P, Rothan HA, Natekar JP, Stone S, Pathak H, Strate PG, et al.. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice. Viruses. 2021;13(1). doi: 10.3390/v13010132</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010132</ArticleId><ArticleId IdType="pmc">PMC7832889</ArticleId><ArticleId IdType="pubmed">33477869</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler ES, Chen RE, Alam F, Yildiz S, Case JB, Uccellini MB, et al.. SARS-CoV-2 causes lung infection without severe disease in human ACE2 knock-in mice. J Virol. 2021:JVI0151121. doi: 10.1128/JVI.01511-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01511-21</ArticleId><ArticleId IdType="pmc">PMC8754206</ArticleId><ArticleId IdType="pubmed">34668780</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathnasinghe R, Strohmeier S, Amanat F, Gillespie VL, Krammer F, Garcia-Sastre A, et al.. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection. Emerg Microbes Infect. 2020;9(1):2433&#x2013;45. doi: 10.1080/22221751.2020.1838955</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1838955</ArticleId><ArticleId IdType="pmc">PMC7655046</ArticleId><ArticleId IdType="pubmed">33073694</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler ES, Bailey AL, Kafai NM, Nair S, McCune BT, Yu J, et al.. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat Immunol. 2020;21(11):1327&#x2013;35. doi: 10.1038/s41590-020-0778-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0778-2</ArticleId><ArticleId IdType="pmc">PMC7578095</ArticleId><ArticleId IdType="pubmed">32839612</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, Thao TTN, Hoffmann D, Taddeo A, Ebert N, Labroussaa F, et al.. SARS-CoV-2 spike D614G change enhances replication and transmission. Nature. 2021;592(7852):122&#x2013;7. doi: 10.1038/s41586-021-03361-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03361-1</ArticleId><ArticleId IdType="pubmed">33636719</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan AO, Case JB, Winkler ES, Thackray LB, Kafai NM, Bailey AL, et al.. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies. Cell. 2020;182(3):744&#x2013;53 e4. doi: 10.1016/j.cell.2020.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.011</ArticleId><ArticleId IdType="pmc">PMC7284254</ArticleId><ArticleId IdType="pubmed">32553273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YI, Kim SG, Kim SM, Kim EH, Park SJ, Yu KM, et al.. Infection and Rapid Transmission of SARS-CoV-2 in Ferrets. Cell Host Microbe. 2020;27(5):704&#x2013;9 e2. doi: 10.1016/j.chom.2020.03.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.03.023</ArticleId><ArticleId IdType="pmc">PMC7144857</ArticleId><ArticleId IdType="pubmed">32259477</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan KA, Bewley KR, Fotheringham SA, Slack GS, Brown P, Hall Y, et al.. Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity. Nat Commun. 2021;12(1):81. doi: 10.1038/s41467-020-20439-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20439-y</ArticleId><ArticleId IdType="pmc">PMC7782478</ArticleId><ArticleId IdType="pubmed">33398055</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlottau K, Rissmann M, Graaf A, Schon J, Sehl J, Wylezich C, et al.. SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study. Lancet Microbe. 2020;1(5):e218&#x2013;e225. doi: 10.1016/S2666-5247(20)30089-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30089-6</ArticleId><ArticleId IdType="pmc">PMC7340389</ArticleId><ArticleId IdType="pubmed">32838346</ArticleId></ArticleIdList></Reference><Reference><Citation>Salguero FJ, White AD, Slack GS, Fotheringham SA, Bewley KR, Gooch KE, et al.. Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19. Nat Commun. 2021;12(1):1260. doi: 10.1038/s41467-021-21389-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21389-9</ArticleId><ArticleId IdType="pmc">PMC7904795</ArticleId><ArticleId IdType="pubmed">33627662</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockx B, Kuiken T, Herfst S, Bestebroer T, Lamers MM, Oude Munnink BB, et al.. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science. 2020;368(6494):1012&#x2013;5. doi: 10.1126/science.abb7314</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb7314</ArticleId><ArticleId IdType="pmc">PMC7164679</ArticleId><ArticleId IdType="pubmed">32303590</ArticleId></ArticleIdList></Reference><Reference><Citation>Munster VJ, Feldmann F, Williamson BN, van Doremalen N, Perez-Perez L, Schulz J, et al.. Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature. 2020;585(7824):268&#x2013;72. doi: 10.1038/s41586-020-2324-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2324-7</ArticleId><ArticleId IdType="pmc">PMC7486227</ArticleId><ArticleId IdType="pubmed">32396922</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H, Li H, Guo L, Liang Y, Li J, Wang X, et al.. Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A non-human primate model of COVID-19 progression. PLoS Pathog. 2020;16(11):e1008949. doi: 10.1371/journal.ppat.1008949</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008949</ArticleId><ArticleId IdType="pmc">PMC7660522</ArticleId><ArticleId IdType="pubmed">33180882</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrashekar A, Liu J, Martinot AJ, McMahan K, Mercado NB, Peter L, et al.. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;369(6505):812&#x2013;7. doi: 10.1126/science.abc4776</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc4776</ArticleId><ArticleId IdType="pmc">PMC7243369</ArticleId><ArticleId IdType="pubmed">32434946</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolsey C, Borisevich V, Prasad AN, Agans KN, Deer DJ, Dobias NS, et al.. Establishment of an African green monkey model for COVID-19 and protection against re-infection. Nat Immunol. 2021;22(1):86&#x2013;98. doi: 10.1038/s41590-020-00835-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00835-8</ArticleId><ArticleId IdType="pmc">PMC7790436</ArticleId><ArticleId IdType="pubmed">33235385</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhakal S, Ruiz-Bedoya CA, Zhou R, Creisher PS, Villano JS, Littlefield K, et al.. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model. MBio. 2021;12(4):e0097421. doi: 10.1128/mBio.00974-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00974-21</ArticleId><ArticleId IdType="pmc">PMC8406232</ArticleId><ArticleId IdType="pubmed">34253053</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouailles G, Wyler E, Pennitz P, Postmus D, Vladimirova D, Kazmierski J, et al.. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19. Nat Commun. 2021;12(1):4869. doi: 10.1038/s41467-021-25030-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25030-7</ArticleId><ArticleId IdType="pmc">PMC8357947</ArticleId><ArticleId IdType="pubmed">34381043</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoagland DA, Moller R, Uhl SA, Oishi K, Frere J, Golynker I, et al.. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity. Immunity. 2021;54(3):557&#x2013;70 e5. doi: 10.1016/j.immuni.2021.01.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.01.017</ArticleId><ArticleId IdType="pmc">PMC7846242</ArticleId><ArticleId IdType="pubmed">33577760</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Yang L, Nilsson-Payant B, Han Y, Jaffre F, Zhu J, et al.. SARS-CoV-2 Infected Cardiomyocytes Recruit Monocytes by Secreting CCL2. Res Sq. 2020. doi: 10.21203/rs.3.rs-94634/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-94634/v1</ArticleId><ArticleId IdType="pmc">PMC7685325</ArticleId><ArticleId IdType="pubmed">33236003</ArticleId></ArticleIdList></Reference><Reference><Citation>Mele D, Flamigni F, Rapezzi C, Ferrari R. Myocarditis in COVID-19 patients: current problems. Intern Emerg Med. 2021. doi: 10.1007/s11739-021-02635-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-021-02635-w</ArticleId><ArticleId IdType="pmc">PMC7823176</ArticleId><ArticleId IdType="pubmed">33484452</ArticleId></ArticleIdList></Reference><Reference><Citation>Craver R, Huber S, Sandomirsky M, McKenna D, Schieffelin J, Finger L. Fatal Eosinophilic Myocarditis in a Healthy 17-Year-Old Male with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2c). Fetal Pediatr Pathol. 2020;39(3):263&#x2013;8. doi: 10.1080/15513815.2020.1761491</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15513815.2020.1761491</ArticleId><ArticleId IdType="pmc">PMC7232882</ArticleId><ArticleId IdType="pubmed">32401577</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizvi ZA, Dalal R, Sadhu S, Binayke A, Dandotiya J, Kumar Y, et al.. Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection. Elife. 2022;11. doi: 10.7554/eLife.73522</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.73522</ArticleId><ArticleId IdType="pmc">PMC8794466</ArticleId><ArticleId IdType="pubmed">35014610</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F, et al.. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med. 2021;13(596). doi: 10.1126/scitranslmed.abf8396</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryche B, St Albin A, Murri S, Lacote S, Pulido C, Ar Gouilh M, et al.. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain Behav Immun. 2020;89:579&#x2013;86. doi: 10.1016/j.bbi.2020.06.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.06.032</ArticleId><ArticleId IdType="pmc">PMC7332942</ArticleId><ArticleId IdType="pubmed">32629042</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K, Jakubowska P, Von Bartheld CS, Butowt R. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age. ACS Chem Nerosci. 2020;11(11):1555&#x2013;62. doi: 10.1021/acschemneuro.0c00210</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00210</ArticleId><ArticleId IdType="pmc">PMC7241737</ArticleId><ArticleId IdType="pubmed">32379417</ArticleId></ArticleIdList></Reference><Reference><Citation>Wruck W, Adjaye J. SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress. Sci Rep. 2020;10(1):21415. doi: 10.1038/s41598-020-78402-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-78402-2</ArticleId><ArticleId IdType="pmc">PMC7723043</ArticleId><ArticleId IdType="pubmed">33293627</ArticleId></ArticleIdList></Reference><Reference><Citation>Aktas O, Ullrich O, Infante-Duarte C, Nitsch R, Zipp F. Neuronal damage in brain inflammation. Arch Neurol. 2007;64(2):185&#x2013;9. doi: 10.1001/archneur.64.2.185</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.64.2.185</ArticleId><ArticleId IdType="pubmed">17296833</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyna RA, Kishimoto-Urata M, Urata S, Makishima T, Paessler S, Maruyama J. Recovery of anosmia in hamsters infected with SARS-CoV-2 is correlated with repair of the olfactory epithelium. Sci Rep. 2022;12(1):628. doi: 10.1038/s41598-021-04622-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-04622-9</ArticleId><ArticleId IdType="pmc">PMC8755745</ArticleId><ArticleId IdType="pubmed">35022504</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis SM, Williams A, Eisenbarth SC. Structure and function of the immune system in the spleen. Sci Immunol. 2019;4(33). doi: 10.1126/sciimmunol.aau6085</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aau6085</ArticleId><ArticleId IdType="pmc">PMC6495537</ArticleId><ArticleId IdType="pubmed">30824527</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh V, Parida D, Minz AP, Sethi M, Sahoo BS, Senapati S. Tissue Distribution of ACE2 Protein in Syrian Golden Hamster (Mesocricetus auratus) and Its Possible Implications in SARS-CoV-2 Related Studies. Front Pharmacol. 2020;11:579330. doi: 10.3389/fphar.2020.579330</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.579330</ArticleId><ArticleId IdType="pmc">PMC7869018</ArticleId><ArticleId IdType="pubmed">33568991</ArticleId></ArticleIdList></Reference><Reference><Citation>Lean FZX, Nunez A, Spiro S, Priestnall SL, Vreman S, Bailey D, et al.. Differential susceptibility of SARS-CoV-2 in animals: Evidence of ACE2 host receptor distribution in companion animals, livestock and wildlife by immunohistochemical characterisation. Transbound Emerg Dis. 2021. doi: 10.1111/tbed.14232</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tbed.14232</ArticleId><ArticleId IdType="pmc">PMC8447087</ArticleId><ArticleId IdType="pubmed">34245662</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao W, Lau HE, Xie H, Poon VK, Chan CC, Chu H, et al.. SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters. Nat Commun. 2022;13(1):2539. doi: 10.1038/s41467-022-30195-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30195-w</ArticleId><ArticleId IdType="pmc">PMC9085785</ArticleId><ArticleId IdType="pubmed">35534483</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleary SJ, Pitchford SC, Amison RT, Carrington R, Robaina Cabrera CL, Magnen M, et al.. Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology. Br J Pharmacol. 2020;177(21):4851&#x2013;65. doi: 10.1111/bph.15143</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15143</ArticleId><ArticleId IdType="pmc">PMC7283621</ArticleId><ArticleId IdType="pubmed">32462701</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Fontela C, Dowling WE, Funnell SGP, Gsell PS, Riveros-Balta AX, Albrecht RA, et al.. Animal models for COVID-19. Nature. 2020;586(7830):509&#x2013;15. doi: 10.1038/s41586-020-2787-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2787-6</ArticleId><ArticleId IdType="pmc">PMC8136862</ArticleId><ArticleId IdType="pubmed">32967005</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu H, Chen Q, Yang G, He L, Fan H, Deng YQ, et al.. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science. 2020;369(6511):1603&#x2013;7. doi: 10.1126/science.abc4730</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc4730</ArticleId><ArticleId IdType="pmc">PMC7574913</ArticleId><ArticleId IdType="pubmed">32732280</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinnon KH 3rd, Leist SR, Schafer A, Edwards CE, Martinez DR, Montgomery SA, et al.. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature. 2020;586(7830):560&#x2013;6. doi: 10.1038/s41586-020-2708-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2708-8</ArticleId><ArticleId IdType="pmc">PMC8034761</ArticleId><ArticleId IdType="pubmed">32854108</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao L, Deng W, Huang B, Gao H, Liu J, Ren L, et al.. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020;583(7818):830&#x2013;3. doi: 10.1038/s41586-020-2312-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2312-y</ArticleId><ArticleId IdType="pubmed">32380511</ArticleId></ArticleIdList></Reference><Reference><Citation>Yinda CK, Port JR, Bushmaker T, Offei Owusu I, Purushotham JN, Avanzato VA, et al.. K18-hACE2 mice develop respiratory disease resembling severe COVID-19. PLoS Pathog. 2021;17(1):e1009195. doi: 10.1371/journal.ppat.1009195</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009195</ArticleId><ArticleId IdType="pmc">PMC7875348</ArticleId><ArticleId IdType="pubmed">33465158</ArticleId></ArticleIdList></Reference><Reference><Citation>McCray PB Jr, Pewe L, Wohlford-Lenane C, Hickey M, Manzel L, Shi L, et al.. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol. 2007;81(2):813&#x2013;21. doi: 10.1128/JVI.02012-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02012-06</ArticleId><ArticleId IdType="pmc">PMC1797474</ArticleId><ArticleId IdType="pubmed">17079315</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang RD, Liu MQ, Chen Y, Shan C, Zhou YW, Shen XR, et al.. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2. Cell. 2020;182(1):50&#x2013;8 e8. doi: 10.1016/j.cell.2020.05.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.027</ArticleId><ArticleId IdType="pmc">PMC7241398</ArticleId><ArticleId IdType="pubmed">32516571</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Wong LR, Li K, Verma AK, Ortiz ME, Wohlford-Lenane C, et al.. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature. 2021;589(7843):603&#x2013;7. doi: 10.1038/s41586-020-2943-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2943-z</ArticleId><ArticleId IdType="pmc">PMC7855185</ArticleId><ArticleId IdType="pubmed">33166988</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli V, Rava M, Marotta D, Di Lucia P, Laura C, Sala E, et al.. Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion. Sci Immunol. 2022;7(67):eabl9929. doi: 10.1126/sciimmunol.abl9929</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl9929</ArticleId><ArticleId IdType="pmc">PMC9835999</ArticleId><ArticleId IdType="pubmed">34812647</ArticleId></ArticleIdList></Reference><Reference><Citation>Threadgill DW, Miller DR, Churchill GA, de Villena FP. The collaborative cross: a recombinant inbred mouse population for the systems genetic era. ILAR J. 2011;52(1):24&#x2013;31. doi: 10.1093/ilar.52.1.24</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ilar.52.1.24</ArticleId><ArticleId IdType="pubmed">21411855</ArticleId></ArticleIdList></Reference><Reference><Citation>Brumeanu TD, Vir P, Karim AF, Kar S, Benetiene D, Lok M, et al.. Human-Immune-System (HIS) humanized mouse model (DRAGA: HLA-A2.HLA-DR4.Rag1KO.IL-2RgammacKO.NOD) for COVID-19. Hum Vaccin Immunother. 2022:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9225593</ArticleId><ArticleId IdType="pubmed">35348437</ArticleId></ArticleIdList></Reference><Reference><Citation>Sefik E, Israelow B, Mirza H, Zhao J, Qu R, Kaffe E, et al.. A humanized mouse model of chronic COVID-19. Nat Biotechnol. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9203605</ArticleId><ArticleId IdType="pubmed">34921308</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham JB, Swarts JL, Leist SR, Schafer A, Menachery VD, Gralinski LE, et al.. Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice. PLoS Pathog. 2021;17(1):e1009287. doi: 10.1371/journal.ppat.1009287</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009287</ArticleId><ArticleId IdType="pmc">PMC7875398</ArticleId><ArticleId IdType="pubmed">33513210</ArticleId></ArticleIdList></Reference><Reference><Citation>Enkirch T, von Messling V. Ferret models of viral pathogenesis. Virology. 2015;479&#x2013;80:259&#x2013;20. doi: 10.1016/j.virol.2015.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.03.017</ArticleId><ArticleId IdType="pmc">PMC7111696</ArticleId><ArticleId IdType="pubmed">25816764</ArticleId></ArticleIdList></Reference><Reference><Citation>Rioux M, McNeil M, Francis ME, Dawe N, Foley M, Langley JM, et al.. The Power of First Impressions: Can Influenza Imprinting during Infancy Inform Vaccine Design? Vaccines (Basel). 2020;8(3). doi: 10.3390/vaccines8030546</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines8030546</ArticleId><ArticleId IdType="pmc">PMC7563765</ArticleId><ArticleId IdType="pubmed">32961707</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SS, Banner D, Degousee N, Leon AJ, Xu L, Paquette SG, et al.. Differential pathological and immune responses in newly weaned ferrets are associated with a mild clinical outcome of pandemic 2009 H1N1 infection. J Virol. 2012;86(24):13187&#x2013;201. doi: 10.1128/JVI.01456-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01456-12</ArticleId><ArticleId IdType="pmc">PMC3503035</ArticleId><ArticleId IdType="pubmed">23055557</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquette SG, Banner D, Huang SS, Almansa R, Leon A, Xu L, et al.. Influenza Transmission in the Mother-Infant Dyad Leads to Severe Disease, Mammary Gland Infection, and Pathogenesis by Regulating Host Responses. PLoS Pathog. 2015;11(10):e1005173. doi: 10.1371/journal.ppat.1005173</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005173</ArticleId><ArticleId IdType="pmc">PMC4598190</ArticleId><ArticleId IdType="pubmed">26448646</ArticleId></ArticleIdList></Reference><Reference><Citation>Bissel SJ, Carter CE, Wang G, Johnson SK, Lashua LP, Kelvin AA, et al.. Age-Related Pathology Associated with H1N1 A/California/07/2009 Influenza Virus Infection. Am J Pathol. 2019;189(12):2389&#x2013;99. doi: 10.1016/j.ajpath.2019.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2019.08.017</ArticleId><ArticleId IdType="pmc">PMC6893900</ArticleId><ArticleId IdType="pubmed">31585069</ArticleId></ArticleIdList></Reference><Reference><Citation>Coates DM, Husseini RH, Collie MH, Sweet C, Smith H. The role of cellular susceptibility in the declining severity of respiratory Influenza of ferrets with age. Br J Exp Pathol. 1984;65(1):29&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2040949</ArticleId><ArticleId IdType="pubmed">6365145</ArticleId></ArticleIdList></Reference><Reference><Citation>Husseini RH, Collie MH, Rushton DI, Sweet C, Smith H. The role of naturally-acquired bacterial infection in influenza-related death in neonatal ferrets. Br J Exp Pathol. 1983;64(5):559&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2040817</ArticleId><ArticleId IdType="pubmed">6639875</ArticleId></ArticleIdList></Reference><Reference><Citation>Collie MH, Rushton DI, Sweet C, Smith H. Studies of influenza virus infection in newborn ferrets. J Med Microbiol. 1980;13(4):561&#x2013;71. doi: 10.1099/00222615-13-4-561</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/00222615-13-4-561</ArticleId><ArticleId IdType="pubmed">7431374</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweet C, Toms GL, Smith H. The pregnant ferret as a model for studying the congenital effects of influenza virus infection in utero: infection of foetal tissues in organ culture and in vivo. Br J Exp Pathol. 1977;58(2):113&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2041280</ArticleId><ArticleId IdType="pubmed">861161</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakeman KJ, Smith H, Sweet C. Mechanism of immunity to Influenza: maternal and passive neonatal protection following immunization of adult ferrets with a live vaccinia-influenza virus haemagglutinin recombinant but not with recombinants containing other influenza virus proteins. J Gen Virol. 1989;70(Pt 6):1523&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">2732721</ArticleId></ArticleIdList></Reference><Reference><Citation>Rushton DI, Collie MH, Sweet C, Husseini RH, Smith H. The effects of maternal influenzal viraemia in late gestation on the conceptus of the pregnant ferret. J Pathol. 1983;140(3):181&#x2013;91. doi: 10.1002/path.1711400302</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1711400302</ArticleId><ArticleId IdType="pubmed">6864368</ArticleId></ArticleIdList></Reference><Reference><Citation>Albrecht RA, Liu WC, Sant AJ, Tompkins SM, Pekosz A, Meliopoulos V, et al.. Moving Forward. Recent Developments for the Ferret Biomedical Research Model. mBio. 2018;9(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6050969</ArticleId><ArticleId IdType="pubmed">30018107</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J, Tai CM, Hurt AC, Tan HX, Kent SJ, Wheatley AK. Sequencing B cell receptors from ferrets (Mustela putorius furo). PLoS ONE. 2020;15(5):e0233794. doi: 10.1371/journal.pone.0233794</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0233794</ArticleId><ArticleId IdType="pmc">PMC7259655</ArticleId><ArticleId IdType="pubmed">32470013</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang W, Wong J, Tan HX, Kelly HG, Whitney PG, Barr I, et al.. Screening and development of monoclonal antibodies for identification of ferret T follicular helper cells. Sci Rep. 2021;11(1):1864. doi: 10.1038/s41598-021-81389-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-81389-z</ArticleId><ArticleId IdType="pmc">PMC7820401</ArticleId><ArticleId IdType="pubmed">33479388</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon AJ, Banner D, Xu L, Ran L, Peng Z, Yi K, et al.. Sequencing, annotation, and characterization of the influenza ferret infectome. J Virol. 2013;87(4):1957&#x2013;66. doi: 10.1128/JVI.02476-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02476-12</ArticleId><ArticleId IdType="pmc">PMC3571481</ArticleId><ArticleId IdType="pubmed">23236062</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng X, Alfoldi J, Gori K, Eisfeld AJ, Tyler SR, Tisoncik-Go J, et al.. The draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory disease. Nat Biotechnol. 2014;32(12):1250&#x2013;5. doi: 10.1038/nbt.3079</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3079</ArticleId><ArticleId IdType="pmc">PMC4262547</ArticleId><ArticleId IdType="pubmed">25402615</ArticleId></ArticleIdList></Reference><Reference><Citation>Heindel DW, Koppolu S, Zhang Y, Kasper B, Meche L, Vaiana CA, et al.. Glycomic analysis of host response reveals high mannose as a key mediator of influenza severity. Proc Natl Acad Sci U S A. 2020;117(43):26926&#x2013;35. doi: 10.1073/pnas.2008203117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2008203117</ArticleId><ArticleId IdType="pmc">PMC7604487</ArticleId><ArticleId IdType="pubmed">33046650</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamoto A, Taguchi F, Fukushi S, Morikawa S, Yamada YK. Identification of ferret ACE2 and its receptor function for SARS-coronavirus. Adv Exp Med Biol. 2006;581:519&#x2013;22. doi: 10.1007/978-0-387-33012-9_93</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-0-387-33012-9_93</ArticleId><ArticleId IdType="pmc">PMC7123533</ArticleId><ArticleId IdType="pubmed">17037589</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu YK, Ali GD, Jia F, Li Q, Kelvin D, Couch RC, et al.. The SARS-CoV ferret model in an infection-challenge study. Virology. 2008;374(1):151&#x2013;63. doi: 10.1016/j.virol.2007.12.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2007.12.032</ArticleId><ArticleId IdType="pmc">PMC2831213</ArticleId><ArticleId IdType="pubmed">18234270</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron MJ, Kelvin AA, Leon AJ, Cameron CM, Ran L, Xu L, et al.. Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model. PLoS ONE. 2012;7(9):e45842. doi: 10.1371/journal.pone.0045842</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045842</ArticleId><ArticleId IdType="pmc">PMC3454321</ArticleId><ArticleId IdType="pubmed">23029269</ArticleId></ArticleIdList></Reference><Reference><Citation>See RH, Petric M, Lawrence DJ, Mok CPY, Rowe T, Zitzow LA, et al.. Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines. J Gen Virol. 2008;89(Pt 9):2136&#x2013;46. doi: 10.1099/vir.0.2008/001891-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.2008/001891-0</ArticleId><ArticleId IdType="pubmed">18753223</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard M, Kok A, de Meulder D, Bestebroer TM, Lamers MM, Okba NMA, et al.. SARS-CoV-2 is transmitted via contact and via the air between ferrets. Nat Commun. 2020;11(1). doi: 10.1038/s41467-020-17367-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17367-2</ArticleId><ArticleId IdType="pmc">PMC7343828</ArticleId><ArticleId IdType="pubmed">32641684</ArticleId></ArticleIdList></Reference><Reference><Citation>Kutter JS, de Meulder D, Bestebroer TM, Lexmond P, Mulders A, Richard M, et al.. SARS-CoV and SARS-CoV-2 are transmitted through the air between ferrets over more than one meter distance. Nat Commun. 2021;12(1). doi: 10.1038/s41467-021-21918-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21918-6</ArticleId><ArticleId IdType="pmc">PMC7955093</ArticleId><ArticleId IdType="pubmed">33712573</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis M. E. RB, McNeil M., Rioux M., Foley M. K., Ge A., Pechous R. D., et al.. Male sex and age biases viral burden, viral shedding, and type 1 and 2 interferon responses during SARS-CoV-2 infection in ferrets. Forthcoming at Sci Rep. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8282673</ArticleId><ArticleId IdType="pubmed">34267262</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis ME, Richardson B, Goncin U, McNeil M, Rioux M, Foley MK, et al.. Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets. Sci Rep. 2021;11(1):14536. doi: 10.1038/s41598-021-93855-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93855-9</ArticleId><ArticleId IdType="pmc">PMC8282673</ArticleId><ArticleId IdType="pubmed">34267262</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YI, Yu KM, Koh JY, Kim EH, Kim SM, Kim EJ, et al.. Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets. Nat Commun. 2022;13(1):21. doi: 10.1038/s41467-021-27717-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27717-3</ArticleId><ArticleId IdType="pmc">PMC8748994</ArticleId><ArticleId IdType="pubmed">35013229</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu P, Qi F, Xu Y, Li F, Liu P, Liu J, et al.. Age-related rhesus macaque models of COVID-19. Animal Model Exp Med. 2020;3(1):93&#x2013;7. doi: 10.1002/ame2.12108</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ame2.12108</ArticleId><ArticleId IdType="pmc">PMC7167234</ArticleId><ArticleId IdType="pubmed">32318665</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman C, Doyle-Meyers LA, Russell-Lodrigue KE, Golden N, Threeton B, Song K, et al.. Similarities and Differences in the Acute-Phase Response to SARS-CoV-2 in Rhesus Macaques and African Green Monkeys. Front Immunol. 2021;12:754642. doi: 10.3389/fimmu.2021.754642</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.754642</ArticleId><ArticleId IdType="pmc">PMC8527883</ArticleId><ArticleId IdType="pubmed">34691074</ArticleId></ArticleIdList></Reference><Reference><Citation>Langel SN, Garrido C, Phan C, Travieso T, DeMarco T, Ma Z-M, et al.. Distinct upper airway epithelium interferon-stimulated and profibrotic gene expression between adult and infant rhesus macaques infected with SARS-CoV-2. BioRxiv 2022.</Citation></Reference><Reference><Citation>Boszormenyi KP, Stammes MA, Fagrouch ZC, Kiemenyi-Kayere G, Niphuis H, Mortier D, et al.. The Post-Acute Phase of SARS-CoV-2 Infection in Two Macaque Species Is Associated with Signs of Ongoing Virus Replication and Pathology in Pulmonary and Extrapulmonary Tissues. Viruses. 2021;13(8). doi: 10.3390/v13081673</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13081673</ArticleId><ArticleId IdType="pmc">PMC8402919</ArticleId><ArticleId IdType="pubmed">34452537</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahlberg MD, Blair RV, Doyle-Meyers LA, Midkiff CC, Zenere G, Russell-Lodrigue KE, et al.. Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates. Nat Commun. 2020;11(1):6078. doi: 10.1038/s41467-020-19967-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19967-4</ArticleId><ArticleId IdType="pmc">PMC7695721</ArticleId><ArticleId IdType="pubmed">33247138</ArticleId></ArticleIdList></Reference><Reference><Citation>Everett HE, Lean FZX, Byrne AMP, van Diemen PM, Rhodes S, James J, et al.. Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection. Viruses. 2021;13(1). doi: 10.3390/v13010113</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010113</ArticleId><ArticleId IdType="pmc">PMC7830262</ArticleId><ArticleId IdType="pubmed">33467732</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes A, Wrenn CC, Harris AP, Thayer KE, Crawley JN. Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice. Genes Brain Behav. 2002;1(1):55&#x2013;69. doi: 10.1046/j.1601-1848.2001.00005.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1601-1848.2001.00005.x</ArticleId><ArticleId IdType="pubmed">12886950</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer N, Orvold IB, Kelvin AA, John G. How land Development of spontaneous tests of olfactory, object, and social discrimination behaviour in male golden hamsters: use in rodent models of SARS-CoV-2 infection?. Fourteenth Annual Meeting of the Canadian Association for Neuroscience Virtual Conference, August 2021.</Citation></Reference><Reference><Citation>Zhang AJ, Lee AC, Chu H, Chan JF, Fan Z, Li C, et al.. Severe Acute Respiratory Syndrome Coronavirus 2 Infects and Damages the Mature and Immature Olfactory Sensory Neurons of Hamsters. Clin Infect Dis. 2021;73(2):e503&#x2013;e512. doi: 10.1093/cid/ciaa995</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa995</ArticleId><ArticleId IdType="pmc">PMC7454453</ArticleId><ArticleId IdType="pubmed">32667973</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoonheim MM, Hulst HE, Brandt RB, Strik M, Wink AM, Uitdehaag BM, et al.. Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis. Neurology. 2015;84(8):776&#x2013;83. doi: 10.1212/WNL.0000000000001285</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001285</ArticleId><ArticleId IdType="pubmed">25616483</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman EJ, Ge Y, Jensen JH, Babb JS, Miles L, Reaume J, et al.. Thalamus and cognitive impairment in mild traumatic brain injury: a diffusional kurtosis imaging study. J Neurotrauma. 2012;29(13):2318&#x2013;27. doi: 10.1089/neu.2011.1763</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2011.1763</ArticleId><ArticleId IdType="pmc">PMC3430483</ArticleId><ArticleId IdType="pubmed">21639753</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Jia X, Liang P, Qi Z, Yang Y, Zhou W, et al.. Changes in thalamus connectivity in mild cognitive impairment: evidence from resting state fMRI. Eur J Radiol. 2012;81(2):277&#x2013;85. doi: 10.1016/j.ejrad.2010.12.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2010.12.044</ArticleId><ArticleId IdType="pubmed">21273022</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa-Ishii S, Shimada A, Imamura F. Lipopolysaccharide-initiated persistent rhinitis causes gliosis and synaptic loss in the olfactory bulb. Sci Rep. 2017;7(1):11605. doi: 10.1038/s41598-017-10229-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-10229-w</ArticleId><ArticleId IdType="pmc">PMC5599676</ArticleId><ArticleId IdType="pubmed">28912588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa-Ishii S, Shimada A, Imamura F. Neuroplastic changes in the olfactory bulb associated with nasal inflammation in mice. J Allergy Clin Immunol. 2019;143(3):978&#x2013;89 e3. doi: 10.1016/j.jaci.2018.09.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.09.028</ArticleId><ArticleId IdType="pubmed">30315829</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitcroft KL, Hummel T. Olfactory Dysfunction in COVID-19: Diagnosis and Management. JAMA. 2020;323(24):2512&#x2013;4. doi: 10.1001/jama.2020.8391</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.8391</ArticleId><ArticleId IdType="pubmed">32432682</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliezer M, Hautefort C, Hamel A-L, Verillaud B, Herman P, Houdart E, et al.. Sudden and Complete Olfactory Loss of Function as a Possible Symptom of COVID-19. JAMA Otolaryngol Head Neck Surg. 2020;146(7):674&#x2013;5. doi: 10.1001/jamaoto.2020.0832</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2020.0832</ArticleId><ArticleId IdType="pubmed">32267483</ArticleId></ArticleIdList></Reference><Reference><Citation>Athanassi A, Dorado Doncel R, Bath KG, Mandairon N. Relationship between depression and olfactory sensory function: a review. Chem Senses. 2021;46. doi: 10.1093/chemse/bjab044</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjab044</ArticleId><ArticleId IdType="pmc">PMC8542994</ArticleId><ArticleId IdType="pubmed">34618883</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohli P, Soler ZM, Nguyen SA, Muus JS, Schlosser RJ. The Association Between Olfaction and Depression: A Systematic Review. Chem Senses. 2016;41(6):479&#x2013;86. doi: 10.1093/chemse/bjw061</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjw061</ArticleId><ArticleId IdType="pmc">PMC4918728</ArticleId><ArticleId IdType="pubmed">27170667</ArticleId></ArticleIdList></Reference><Reference><Citation>Rioux M, Francis ME, Swan CL, Ge A, Kroeker A, Kelvin AA. The Intersection of Age and Influenza Severity: Utility of Ferrets for Dissecting the Age-Dependent Immune Responses and Relevance to Age-Specific Vaccine Development. Viruses. 2021;13(4):678. doi: 10.3390/v13040678</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040678</ArticleId><ArticleId IdType="pmc">PMC8071347</ArticleId><ArticleId IdType="pubmed">33920917</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis MEMM, Dawe NJ, Foley MK, King ML, Ross TM, Kelvin AA. Historical H1N1 influenza virus imprinting increases vaccine protection by influencing the activity and sustained production of antibodies elicited at vaccination in ferrets. Vaccine. 2019. doi: 10.3390/vaccines7040133</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines7040133</ArticleId><ArticleId IdType="pmc">PMC6963198</ArticleId><ArticleId IdType="pubmed">31569351</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquette SG, Huang SS, Banner D, Xu L, Leomicronn A, Kelvin AA, et al.. Impaired heterologous immunity in aged ferrets during sequential Influenza A H1N1 infection. Virology. 2014;464&#x2013;5:177&#x2013;83. doi: 10.1016/j.virol.2014.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2014.07.013</ArticleId><ArticleId IdType="pmc">PMC4157083</ArticleId><ArticleId IdType="pubmed">25086242</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis ME, McNeil M, Dawe NJ, Foley MK, King ML, Ross TM, et al.. Historical H1N1 Influenza Virus Imprinting Increases Vaccine Protection by Influencing the Activity and Sustained Production of Antibodies Elicited at Vaccination in Ferrets. Vaccines (Basel). 2019;7(4). doi: 10.3390/vaccines7040133</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines7040133</ArticleId><ArticleId IdType="pmc">PMC6963198</ArticleId><ArticleId IdType="pubmed">31569351</ArticleId></ArticleIdList></Reference><Reference><Citation>Music N, Tzeng WP, Liaini Gross F, Levine MZ, Xu X, Shieh WJ, et al.. Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets. NPJ Vaccines. 2019;4:28. doi: 10.1038/s41541-019-0123-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-019-0123-7</ArticleId><ArticleId IdType="pmc">PMC6616337</ArticleId><ArticleId IdType="pubmed">31312528</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair RV, Vaccari M, Doyle-Meyers LA, Roy CJ, Russell-Lodrigue K, Fahlberg M, et al.. Acute Respiratory Distress in Aged, SARS-CoV-2-Infected African Green Monkeys but Not Rhesus Macaques. Am J Pathol. 2021;191(2):274&#x2013;82. doi: 10.1016/j.ajpath.2020.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2020.10.016</ArticleId><ArticleId IdType="pmc">PMC7648506</ArticleId><ArticleId IdType="pubmed">33171111</ArticleId></ArticleIdList></Reference><Reference><Citation>Umesh A, Pranay K, Pandey RC, Gupta MK. Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism. Infection. 2022. doi: 10.1007/s15010-022-01835-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01835-6</ArticleId><ArticleId IdType="pmc">PMC9055372</ArticleId><ArticleId IdType="pubmed">35489015</ArticleId></ArticleIdList></Reference><Reference><Citation>Burge DJ, Eisenman J, Byrnes-Blake K, Smolak P, Lau K, Cohen SB, et al.. Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study. Lupus. 2017;26(8):825&#x2013;34. doi: 10.1177/0961203316678675</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316678675</ArticleId><ArticleId IdType="pubmed">27852935</ArticleId></ArticleIdList></Reference><Reference><Citation>Posada J, Valadkhan S, Burge D, Davies K, Tarn J, Casement J, et al.. Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjogren&#x2019;s Syndrome: A Randomized Clinical Trial. Arthritis Rheumatol. 2021;73(1):143&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7839752</ArticleId><ArticleId IdType="pubmed">32798283</ArticleId></ArticleIdList></Reference><Reference><Citation>Abusalamah H, Reel JM, Lupfer CR. Pyruvate affects inflammatory responses of macrophages during Influenza A virus infection. Virus Res. 2020;286:198088. doi: 10.1016/j.virusres.2020.198088</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198088</ArticleId><ArticleId IdType="pmc">PMC7345311</ArticleId><ArticleId IdType="pubmed">32634445</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupfer CRNR, Amen R, Martin A. Inhalation of Sodium Pyruvate to Reduce the Symptoms and Severity of Respiratory Diseases Including COVID-19, Long COVID, and Pulmonary Fibrosis. Eur J Respir Med. 2021;3(3).</Citation></Reference><Reference><Citation>Mehmel M, Jovanovic N, Spitz U. Nicotinamide Riboside-The Current State of Research and Therapeutic Uses. Nutrients. 2020;12(6). doi: 10.3390/nu12061616</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12061616</ArticleId><ArticleId IdType="pmc">PMC7352172</ArticleId><ArticleId IdType="pubmed">32486488</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>